A phase Ib/II study of BBI608 combined with weekly paclitaxel in advanced pancreatic cancer.

被引：7
|
作者：
Bekaii-Saab, Tanios S.
Mikhail, Sameh
Langleben, Adrian
Becerra, Carlos
Jonker, Derek J.
Asmis, Timothy R.
Cote, Gregory Michael
Wu, Christina Sing-Ying
Kwak, Eunice Lee
Spira, Alexander I.
Braiteh, Fadi S.
Richey, Stephen Lane
Hume, Stephanie
Hitron, Matthew
Li, Chiang
机构：
[1] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Solove Res Inst, Columbus, OH 43210 USA
[2] St Marys Hosp, Westmount, PQ, Canada
[3] Texas Oncol, Baylor Sammons Canc Ctr, Dallas, TX USA
[4] Ottawa Hosp, Ctr Canc, Ottawa, ON, Canada
[5] Massachusetts Gen Hosp, Boston, MA 02114 USA
[6] Ohio State Univ, Ctr Comprehens Canc, Arthur G James Canc Hosp, Richard J Solove Res Inst, Columbus, OH 43210 USA
[7] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[8] Virginia Canc Specialists Res Inst, US Oncol Res, Fairfax, VA USA
[9] McKesson Specialty Hlth, US Oncol Network, The Woodlands, TX USA
[10] Texas Oncol, US Oncol Network, McKesson Specialty Hlth, Ft Worth, TX USA
[11] Boston Biomed Inc, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 04期
关键词：
D O I：
10.1200/jco.2016.34.4_suppl.196
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
196
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase II study of weekly paclitaxel plus 5-fluorouracil in patients with unresectable advanced or recurrent gastric cancer.
    Ninomiya, M
    Kondo, K
    Kojima, H
    Matsuo, K
    Hirabayashi, N
    Nakamura, S
    Kawamura, S
    Kobayashi, M
    Konno, H
    Sakamoto, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 326S - 326S
  • [32] Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II study
    Giuseppe Frasci
    Pasquale Comella
    Giuseppe D'Aiuto
    Alfredo Budillon
    Deborah Barbarulo
    Renato Thomas
    Immacolata Capasso
    Rossana Casaretti
    Antonio Daponte
    Francesco Caponigro
    Adriano Gravina
    Luigi Maiorino
    Giacomo Caratení
    Alfonso Gentile
    Giuseppe Comella
    Breast Cancer Research and Treatment, 1998, 49 : 13 - 26
  • [33] Randomized phase II study comparing dose-escalated weekly paclitaxel versus standard dose weekly paclitaxel for patients with previously treated advanced gastric cancer.
    Shitara, Kohei
    Yuki, Satoshi
    Takahari, Daisuke
    Nakamura, Michio
    Kondo, Chihiro
    Tsuda, Takashi
    Kii, Takayuki
    Tsuji, Yasushi
    Utsunomiya, Setsuo
    Ichikawa, Daisuke
    Hosokawa, Ayumu
    Ishiguro, Atsushi
    Sakai, Daisuke
    Hironaka, Shuichi
    Oze, Isao
    Matsuo, Keitaro
    Muro, Kei
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [34] A Phase I/II trial of weekly gemcitabine with celecoxib and thalidomide for patients with advanced pancreatic cancer.
    Densmore, JJ
    Fox, JR
    Kannarkat, G
    Morgan, JK
    Petroni, G
    Blount, T
    Sullivan, K
    Williams, ME
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 367S - 367S
  • [35] Phase Ib study of gemcitabine, nab-paclitaxel, and ficlatuzumab in patients with advanced pancreatic cancer
    Perez, Kimberly
    Weekes, Colin D.
    Cleary, James M.
    Abrams, Thomas Adam
    Blaszkowsky, Lawrence Scott
    Enzinger, Peter C.
    Giannakis, Marios
    Goyal, Lipika
    Meyerhardt, Jeffrey A.
    Rubinson, Douglas Adam
    Yurgelun, Matthew B.
    Stonely, Danielle
    Raghavan, Srivatsan
    Bakir, Basil
    Das, Koushik
    Pitarresi, Jason
    Aguirre, Andrew
    Needle, Michael N.
    Rustgi, Anil
    Wolpin, Brian M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [36] Phase II study of weekly paclitaxel in patients with advanced gastric cancer in Japan.
    Baba, H
    Emi, Y
    Kakeji, Y
    Tokunaga, E
    Ushiro, S
    Watanabe, M
    Maehara, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 369S - 369S
  • [37] Phase II study of DMXAA combined with carboplatin and paclitaxel in recurrent ovarian cancer.
    Gabra, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 263S - 263S
  • [38] A phase Ib study of napabucasin plus weekly paclitaxel in patients with advanced melanoma.
    Edenfield, William Jeffery
    Becerra, Carlos
    Braiteh, Fadi S.
    Spira, Alexander I.
    Sullivan, Ryan J.
    Panella, Timothy J.
    Li, Wei
    Huang, Janet
    Li, Youzhi
    Flaherty, Keith
    Hitron, Matthew
    Li, Chiang
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [39] Phase II study of a weekly liposomal paclitaxel formulation (Genexol®-PM) and gemcitabine® combination chemotherapy in patients with advanced biliary cancer.
    Uk, Keon Kean Uk
    Kim, Jin Young
    Do, Young Rok
    Song, Hong Suk
    Jeon, Young June
    Ryoo, Hun Mo
    Bae, Sung Hwa
    Kim, Jong Gwang
    Baek, Jin Ho
    Chae, Yee Soo
    Kim, Min Kyoung
    Lee, Kyung Hee
    Cho, Yoon Young
    CANCER RESEARCH, 2013, 73 (08)
  • [40] IMAGE, a randomized phase Ib/II study of elisidepsin in pretreated advanced gastroesophageal cancer.
    Szyldergemajn, S. A.
    Goncalves, A.
    Metges, J. P.
    Gunzer, K.
    Montagut, C.
    Salazar, R.
    Alsina, M.
    Evans, T. R. J.
    Swinson, D.
    Petty, R. D.
    Singer, H.
    Kahatt, C. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345